Source comparison
CJC-1295 DAC vs No DAC: Formulation Determines Dosing Frequency
CJC-1295 with DAC (drug affinity complex) binds to serum albumin after subcutaneous injection, creating a sustained-release effect that prolongs the peptide's active presence in circulation for 6–8 days. This extended bioavailability allows once-weekly dosing
This comparison does not assign a generated winner or score.
- CJC-1295 with DAC (drug affinity complex) binds to serum albumin after subcutaneous injection, creating a sustained-release effect that prolongs the peptide's active presence in circulation for 6–8 days. This extended bioavailability allows once-weekly dosing at 1–2 mg per injection—typically split as 500 mcg twice weekly or 1 mg once weekly depending on protocol design. The DAC modification consists of a lysine linker and a maleimidoproprionic acid moiety that covalently attaches to albumin, dramatically extending the compound's half-life from under 30 minutes to approximately one week.
- CJC-1295 No DAC lacks this albumin-binding modification and has a half-life closer to that of native GHRH—roughly 30 minutes in circulation. This requires multiple daily administrations to sustain elevated GH release. Standard No DAC protocols use 100–200 mcg per dose, administered 1–3 times daily. The most common frequency is twice daily: once upon waking during the natural morning GH pulse window and once before bed during the sleep-associated GH surge. Research-focused protocols often add a third dose pre-workout to leverage exercise-induced GH potentiation.
- The trade-off: DAC formulations provide stable, continuous GHRH receptor activation but create a 'flatter' GH release curve with less dramatic pulsatility. No DAC formulations preserve the pulsatile GH secretion pattern that more closely mimics endogenous physiology—which some evidence suggests may be more favourable for lipolysis and anabolic signalling. The best CJC-1295 dosage growth hormone release 2026 depends on whether the goal is sustained baseline elevation (DAC) or amplified pulsatile peaks (No DAC).